93 related articles for article (PubMed ID: 22626636)
1. SKI-1/S1P inhibition: a promising surrogate to statins to block hepatitis C virus replication.
Blanchet M; Seidah NG; Labonté P
Antiviral Res; 2012 Aug; 95(2):159-66. PubMed ID: 22626636
[TBL] [Abstract][Full Text] [Related]
2. SKI-1/S1P inhibitor PF-429242 impairs the onset of HCV infection.
Blanchet M; Sureau C; Guévin C; Seidah NG; Labonté P
Antiviral Res; 2015 Mar; 115():94-104. PubMed ID: 25573299
[TBL] [Abstract][Full Text] [Related]
3. Human subtilase SKI-1/S1P is a master regulator of the HCV Lifecycle and a potential host cell target for developing indirect-acting antiviral agents.
Olmstead AD; Knecht W; Lazarov I; Dixit SB; Jean F
PLoS Pathog; 2012 Jan; 8(1):e1002468. PubMed ID: 22241994
[TBL] [Abstract][Full Text] [Related]
4. Anti-ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis C.
Ikeda M; Kawai Y; Mori K; Yano M; Abe K; Nishimura G; Dansako H; Ariumi Y; Wakita T; Yamamoto K; Kato N
Liver Int; 2011 Jul; 31(6):871-80. PubMed ID: 21645219
[TBL] [Abstract][Full Text] [Related]
5. Human Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P) regulates cytoplasmic lipid droplet abundance: A potential target for indirect-acting anti-dengue virus agents.
Hyrina A; Meng F; McArthur SJ; Eivemark S; Nabi IR; Jean F
PLoS One; 2017; 12(3):e0174483. PubMed ID: 28339489
[TBL] [Abstract][Full Text] [Related]
6. Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus.
Saito K; Shirasago Y; Suzuki T; Aizaki H; Hanada K; Wakita T; Nishijima M; Fukasawa M
J Virol; 2015 Feb; 89(4):2220-32. PubMed ID: 25473062
[TBL] [Abstract][Full Text] [Related]
7. A cell-based, high-throughput screen for small molecule regulators of hepatitis C virus replication.
Kim SS; Peng LF; Lin W; Choe WH; Sakamoto N; Kato N; Ikeda M; Schreiber SL; Chung RT
Gastroenterology; 2007 Jan; 132(1):311-20. PubMed ID: 17241881
[TBL] [Abstract][Full Text] [Related]
8. Understanding the molecular mechanism of host-based statin resistance in hepatitis C virus replicon containing cells.
Delang L; Scheers E; Grabner M; Verpaalen B; Helsen N; Vanstreels E; Daelemans D; Verfaillie C; Neyts J
Biochem Pharmacol; 2015 Aug; 96(3):190-201. PubMed ID: 26070251
[TBL] [Abstract][Full Text] [Related]
9. Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development.
Delang L; Paeshuyse J; Vliegen I; Leyssen P; Obeid S; Durantel D; Zoulim F; Op de Beeck A; Neyts J
Hepatology; 2009 Jul; 50(1):6-16. PubMed ID: 19437494
[TBL] [Abstract][Full Text] [Related]
10. Suppressive Effects of the Site 1 Protease (S1P) Inhibitor, PF-429242, on Dengue Virus Propagation.
Uchida L; Urata S; Ulanday GE; Takamatsu Y; Yasuda J; Morita K; Hayasaka D
Viruses; 2016 Feb; 8(2):. PubMed ID: 26875984
[TBL] [Abstract][Full Text] [Related]
11. Life style-related diseases of the digestive system: cell culture system for the screening of anti-hepatitis C virus (HCV) reagents: suppression of HCV replication by statins and synergistic action with interferon.
Ikeda M; Kato N
J Pharmacol Sci; 2007 Oct; 105(2):145-50. PubMed ID: 17928739
[TBL] [Abstract][Full Text] [Related]
12. Gene set enrichment analysis reveals several globally affected pathways due to SKI-1/S1P inhibition in HepG2 cells.
De Windt A; Rai M; Bernier L; Thelen K; Soini J; Lefebvre C; Chintawar S; Lavigne J; Saarinen L; Kytömäki L; Munzer JS; Lütjohann D; Pandolfo M; Davignon J; Seidah NG; Laaksonen R
DNA Cell Biol; 2007 Nov; 26(11):765-72. PubMed ID: 17867930
[TBL] [Abstract][Full Text] [Related]
13. Are statins a viable option for the treatment of infections with the hepatitis C virus?
Verpaalen B; Neyts J; Delang L
Antiviral Res; 2014 May; 105():92-9. PubMed ID: 24613180
[TBL] [Abstract][Full Text] [Related]
14. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
[TBL] [Abstract][Full Text] [Related]
15. A serine palmitoyltransferase inhibitor blocks hepatitis C virus replication in human hepatocytes.
Katsume A; Tokunaga Y; Hirata Y; Munakata T; Saito M; Hayashi H; Okamoto K; Ohmori Y; Kusanagi I; Fujiwara S; Tsukuda T; Aoki Y; Klumpp K; Tsukiyama-Kohara K; El-Gohary A; Sudoh M; Kohara M
Gastroenterology; 2013 Oct; 145(4):865-73. PubMed ID: 23791700
[TBL] [Abstract][Full Text] [Related]
16. The kinase-inhibitor sorafenib inhibits multiple steps of the Hepatitis C Virus infectious cycle in vitro.
Descamps V; Helle F; Louandre C; Martin E; Brochot E; Izquierdo L; Fournier C; Hoffmann TW; Castelain S; Duverlie G; Galmiche A; François C
Antiviral Res; 2015 Jun; 118():93-102. PubMed ID: 25823619
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1/site-1 protease inhibitor PF-429242.
Pasquato A; Rochat C; Burri DJ; Pasqual G; de la Torre JC; Kunz S
Virology; 2012 Feb; 423(1):14-22. PubMed ID: 22154237
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyurea as an inhibitor of hepatitis C virus RNA replication.
Nozaki A; Morimoto M; Kondo M; Oshima T; Numata K; Fujisawa S; Kaneko T; Miyajima E; Morita S; Mori K; Ikeda M; Kato N; Tanaka K
Arch Virol; 2010 Apr; 155(4):601-5. PubMed ID: 20204428
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus complete life cycle screen for identification of small molecules with pro- or antiviral activity.
Gentzsch J; Hinkelmann B; Kaderali L; Irschik H; Jansen R; Sasse F; Frank R; Pietschmann T
Antiviral Res; 2011 Feb; 89(2):136-48. PubMed ID: 21167208
[TBL] [Abstract][Full Text] [Related]
20. Different anti-HCV profiles of statins and their potential for combination therapy with interferon.
Ikeda M; Abe K; Yamada M; Dansako H; Naka K; Kato N
Hepatology; 2006 Jul; 44(1):117-25. PubMed ID: 16799963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
